Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

ABIVAX Société Anonyme (PA: ABVX)

 
ABVX Technical Analysis
5
As on 11th Mar 2025 ABVX STOCK Price closed @ 5.91 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 11.68 & Strong Sell for SHORT-TERM with Stoploss of 10.21 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ABVXSTOCK Price

Open 6.20 Change Price %
High 6.27 1 Day -0.22 -3.59
Low 5.81 1 Week -1.03 -14.84
Close 5.91 1 Month -0.03 -0.51
Volume 89630 1 Year -7.43 -55.70
52 Week High 15.18 | 52 Week Low 5.68
 
PA France Most Active Stocks
ATO 0.00 %
ALVER 0.00 %
ALEUP 0.02 -33.33%
FTI 5.91 -1.66%
VIEDS 0.72 4.35%
LAT 0.02 0.00%
ALBOO 0.01 %
ALALO 0.00 %
ALNRG 0.01 0.00%
ORA 11.77 -0.42%
 
PA France Top Gainers Stocks
MLGEQ 0.02 100.00%
MLONL 1.10 20.88%
FIPP 0.13 18.18%
FIPP 0.13 18.18%
FIPP 0.13 18.18%
ALAGR 0.07 16.67%
VTR 11.20 13.13%
VTR 11.20 13.13%
MLTRO 3.10 10.71%
ALORA 0.43 10.26%
 
PA France Top Losers Stocks
AKOM 4.06 -37.05%
AKOM 4.06 -37.05%
FPN 0.02 -33.33%
ALEUP 0.02 -33.33%
MLPHO 0.10 -23.08%
MLIDS 0.31 -16.22%
ORP 7.90 -12.03%
MLMON 0.88 -12.00%
PARRO 7.12 -11.22%
ALUPG 1.97 -10.45%
 
 
ABVX
Daily Charts		 ABVX
Intraday Charts		 Whats New @
Bazaartrend		 ABVX
Free Analysis
 
ABVX Important Levels Intraday
RESISTANCE6.80
RESISTANCE6.51
RESISTANCE6.34
RESISTANCE6.16
SUPPORT5.66
SUPPORT5.48
SUPPORT5.31
SUPPORT5.02
 
ABVX Forecast March 2025
Share
4th UP Forecast14.56
3rd UP Forecast11.79
2nd UP Forecast10.07
1st UP Forecast8.36
1st DOWN Forecast3.46
2nd DOWN Forecast1.75
3rd DOWN Forecast0.03
4th DOWN Forecast-2.74
 
ABVX Weekly Forecast
4th UP Forecast8.80
3rd UP Forecast7.87
2nd UP Forecast7.30
1st UP Forecast6.73
1st DOWN Forecast5.09
2nd DOWN Forecast4.52
3rd DOWN Forecast3.95
4th DOWN Forecast3.02
 
ABVX Forecast2025
4th UP Forecast24.79
3rd UP Forecast18.74
2nd UP Forecast14.99
1st UP Forecast11.25
1st DOWN Forecast0.57
2nd DOWN Forecast-3.17
3rd DOWN Forecast-6.92
4th DOWN Forecast-12.97
 
 
ABVX Other Details
Segment EQ
Market Capital 494349600.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
ABVX Address
ABVX
 
ABVX Latest News
 
Your Comments and Response on ABIVAX Société Anonyme
 
ABVX Business Profile
ABIVAX Société Anonyme discovers and optimizes drugs for the treatment of inflammatory diseases, infectious diseases, and cancer in France. Its principal products include ABX464 that is in Phase IIb clinical trials for the treatment of ulcerative colitis and Crohn's Disease, as well as for COVID-19; Phase IIa clinical trial for the treatment of rheumatoid arthritis diseases; and has completed Phase IIa clinical trial for the treatment of viral remission in patients with HIV. It also develops ABX 196, an immune enhancer candidate that is in Phase 1/2 clinical trials for the treatment of hepatocellular cancer. In addition, the company engages in the research programs for the treatment of Dengue fever, influenza, and respiratory syncytial virus. ABIVAX Société Anonyme has license contracts with the French National Centre for Scientific Research, the University of Montpellier, and the Institut Curie. The company was incorporated in 2013 and is headquartered in Paris, France. Address: 5, rue de la Baume, Paris, France, 75008
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service